Skip to content

Clinical trials

Phase 1 Multiple Sclerosis, Chronic Progressive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Phase: Phase 1 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20111
20141
20151
20181
20211
20222
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting2
Unknown status1
Not yet recruiting1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University2
Abata Therapeutics1
Artielle ImmunoTherapeutics1
Autolus Limited1
Biogen1
Bruce Cree1
Hoffmann-La Roche1
Indapta Therapeutics, INC.1
Joanne Kurtzberg, MD1
Ohio State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive18
Multiple Sclerosis15
Multiple Sclerosis, Relapsing-Remitting5
Autoimmune Diseases2
Demyelinating Diseases2
Autoimmune Diseases of the Nervous System1
Demyelinating Autoimmune Diseases, CNS1
Fatigue1
Immune System Diseases1
Nervous System Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.